Document Detail


Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains.
MedLine Citation:
PMID:  11023190     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Following characterisation by phenotypic tests and amplified ribosomal DNA restriction analysis (ARDRA), 50 tetracycline-resistant (MIC > or = 16 mg/L) Acinetobacter strains from clinical (n = 35) and aquatic (n = 15) samples were analysed by PCR for tetracycline resistance (Tet) determinants of classes A-E. All the clinical strains were A. baumannii; most (33 of 35) had Tet A (n = 16) or B (n = 17) determinants, and only two did not yield amplicons with primers for any of the five tetracycline resistance determinants. The aquatic strains belonged to genomic species other than A. baumannii, and most (12 of 15) did not contain determinants Tet A-E. Strains negative for Tet A-E were also negative for Tet G and M; further analysis of two aquatic strains with specific primers for Tet O and Tet Y and degenerate primers for Tet M-S-O-P(B)-Q also showed negative results. Transfer of tetracycline resistance was tested for 20 strains with three aquatic Acinetobacter strains and Escherichia coli K-12 as recipients. Transfer of resistance was demonstrated between aquatic strains from distinct ecological niches, but not from clinical to aquatic strains, nor from any Acinetobacter strain to E. coli K-12. Most transconjugants acquired multiple relatively small plasmids (<36 kb). Transfer did not occur when DNA from the donor strains was added to the recipient cultures and was not affected by deoxyribonuclease I, suggesting a conjugative mechanism. It is concluded that Tet A and B are widespread among tetracycline-resistant A. baumannii strains of clinical origin, but unknown genetic determinants are responsible for most tetracycline resistance among aquatic Acinetobacter spp. These differences, together with the inability of clinical strains to transfer tetracycline resistance in vitro to aquatic strains, contra-indicate any important flow of tetracycline resistance genes between clinical and aquatic acinetobacter populations.
Authors:
L Guardabassi; L Dijkshoorn; J M Collard; J E Olsen; A Dalsgaard
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of medical microbiology     Volume:  49     ISSN:  0022-2615     ISO Abbreviation:  J. Med. Microbiol.     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-19     Completed Date:  2000-10-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0224131     Medline TA:  J Med Microbiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  929-36     Citation Subset:  IM    
Affiliation:
Department of Veterinary Microbiology, The Royal Veterinary and Agricultural University, Frederiksberg, Denmark. lg@kvl.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acinetobacter / classification,  drug effects*,  genetics
Acinetobacter Infections / drug therapy*,  microbiology
Anti-Bacterial Agents / pharmacology*,  therapeutic use
DNA Primers / chemistry
DNA Restriction Enzymes / chemistry
DNA, Ribosomal / chemistry
Drug Resistance, Microbial
Electrophoresis, Agar Gel
Gene Transfer Techniques
Humans
Plasmids / chemistry
Polymerase Chain Reaction
Tetracycline / pharmacology*,  therapeutic use
Tetracycline Resistance / genetics*
Water Microbiology*
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/DNA Primers; 0/DNA, Ribosomal; 60-54-8/Tetracycline; EC 3.1.21.-/DNA Restriction Enzymes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1...
Next Document:  Characterisation of a new isolate of Mycobacterium shimoidei from Finland.